Imara Plan Targets Sickle Cell Disease Care Gaps in Africa

The Imara Plan, a new regional health initiative, seeks to standardize sickle cell disease (SCD) management across Africa by integrating diagnostic, treatment, and long-term care services into national health systems. Initially launching in Uganda, Kenya, and Côte d’Ivoire, the framework aims to bridge the gap between policy commitments and clinical practice, according to project partners including the Global Coalition Against Sickle Cell Disease.

Why is the Imara Plan necessary for public health?

Africa carries approximately 80% of the global burden of sickle cell disease, with hundreds of thousands of infants born with the condition annually, according to data cited by the World Health Organization (WHO). Despite increased awareness, patients frequently experience fragmented care, diagnostic delays, and insufficient long-term monitoring. The Imara Plan addresses these inefficiencies by providing a structured model that connects primary, secondary, and tertiary care, ensuring that screening and diagnosis lead directly to consistent medical follow-up.

How will the Imara Plan function in participating countries?

The initiative is built around 10 priority intervention areas designed to align with existing national health frameworks rather than duplicating them. By coordinating government agencies, clinical providers, and blood transfusion services, the plan aims to create a continuous patient pathway. In Uganda, Health Minister Dr. Chris Baryomunsi noted that the initiative supports the country’s commitment to improving survival rates and quality of life for children by providing regular, accessible medical monitoring. Similarly, in Kenya, the Ministry of Health is leveraging the Social Health Authority to link diagnostic services with safe blood supplies and coordinated treatment protocols.

What are the expected outcomes for patient care?

The transition from fragmented interventions to a unified system is intended to reduce complications and improve life expectancy. Eyong Ebai, Regional General Manager for Africa at Terumo Blood and Cell Technologies, states that the next phase of public health progress requires translating existing policy priorities into a life-long continuum of care. The plan specifically targets the following improvements:

• Early Detection: Strengthening newborn screening programs to initiate care immediately.
• Service Integration: Ensuring patients move seamlessly between primary health centers and specialized care.
• Resource Coordination: Aligning blood banking, specialized hematology, and patient support networks.

Comparison of Regional Approaches

While global initiatives like those led by the Africa CDC have historically focused on raising awareness and increasing testing capacity, the Imara Plan shifts the focus toward implementation and operational sustainability. Unlike previous broad-based awareness campaigns, Imara provides a practical, country-specific framework. This focus on “closing the loop” between a positive diagnosis and long-term management distinguishes it from earlier, purely diagnostic-focused programs.

The Imara Plan is supported by a coalition of partners, including the Global Coalition Against Sickle Cell Disease and Terumo Blood and Cell Technologies, aiming to establish a scalable model that can be adapted to the specific needs of other nations across the continent.